Conditions: Actinic Keratosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 519
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare safety and efficacy of Perrigo's drug product compared to an FDA approved drug product in the treatment of actinic keratosis.

Detailed description:

Arms:
arm 1: Ingenol Mebutate arm 2: Ingenol Mebutate arm 3: Placebo gel

Interventions: intervention 1: Ingenol Mebutate (Perrigo) intervention 2: Ingenol Mebutate (Reference) intervention 3: Placebo gel
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document:
Prot_001.pdf: 
 
 
NCT02385318 
 
04-15-2015 













































































































SAP_000.pdf: 
 
 
NCT02385318 
 
04-15-2015